Venezuela invalidates patents registered by Bayer for its antibiotic Avelox
The government of Venezuela has invalidated two patents registered in the country by Bayer for its antibiotic Avelox, local reports have confirmed.
Hyderabad-based Natco Pharma limited said that it had successfully opposed a patent application in India that covers the composition of Glatiramer Acetate, the generic version of Teva Pharmaceutical Industries Copaxone.